175 related articles for article (PubMed ID: 26782170)
1. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract][Full Text] [Related]
2. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
[TBL] [Abstract][Full Text] [Related]
3. Fhit loss-associated initiation and progression of neoplasia in vitro.
Karras JR; Schrock MS; Batar B; Zhang J; La Perle K; Druck T; Huebner K
Cancer Sci; 2016 Nov; 107(11):1590-1598. PubMed ID: 27513973
[TBL] [Abstract][Full Text] [Related]
4. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract][Full Text] [Related]
5. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
Saldivar JC; Park D
Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
Zanesi N; Mancini R; Sevignani C; Vecchione A; Kaou M; Valtieri M; Calin GA; Pekarsky Y; Gnarra JR; Croce CM; Huebner K
Cancer Res; 2005 Aug; 65(15):6576-82. PubMed ID: 16061637
[TBL] [Abstract][Full Text] [Related]
8. A Fhit-ing role in the DNA damage checkpoint response.
Ishii H; Wang Y; Huebner K
Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
[TBL] [Abstract][Full Text] [Related]
9. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
[TBL] [Abstract][Full Text] [Related]
10. The tumor spectrum in FHIT-deficient mice.
Zanesi N; Fidanza V; Fong LY; Mancini R; Druck T; Valtieri M; Rüdiger T; McCue PA; Croce CM; Huebner K
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10250-5. PubMed ID: 11517343
[TBL] [Abstract][Full Text] [Related]
11. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
[TBL] [Abstract][Full Text] [Related]
12. Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains.
Sun J; Liu J; Pan X; Quimby D; Zanesi N; Druck T; Pfeifer GP; Croce CM; Fong LY; Huebner K
Carcinogenesis; 2011 Mar; 32(3):351-8. PubMed ID: 21097531
[TBL] [Abstract][Full Text] [Related]
13. Muir-Torre-like syndrome in Fhit-deficient mice.
Fong LY; Fidanza V; Zanesi N; Lock LF; Siracusa LD; Mancini R; Siprashvili Z; Ottey M; Martin SE; Druck T; McCue PA; Croce CM; Huebner K
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4742-7. PubMed ID: 10758156
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted
Volinia S; Druck T; Paisie CA; Schrock MS; Huebner K
Oncotarget; 2017 Nov; 8(60):102199-102211. PubMed ID: 29254236
[TBL] [Abstract][Full Text] [Related]
15. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
16. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
17. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract][Full Text] [Related]
18. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
Ottey M; Han SY; Druck T; Barnoski BL; McCorkell KA; Croce CM; Raventos-Suarez C; Fairchild CR; Wang Y; Huebner K
Br J Cancer; 2004 Nov; 91(9):1669-77. PubMed ID: 15494723
[TBL] [Abstract][Full Text] [Related]
19. The FHIT gene product: tumor suppressor and genome "caretaker".
Waters CE; Saldivar JC; Hosseini SA; Huebner K
Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
[TBL] [Abstract][Full Text] [Related]
20. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]